Summary:
- This article discusses the latest advancements in gene editing technology, specifically the use of CRISPR-Cas9 to treat genetic disorders.
- The researchers have successfully used CRISPR-Cas9 to correct the genetic mutations responsible for sickle cell disease, a debilitating blood disorder, in human embryos.
- The article highlights the potential of this technology to revolutionize the treatment of genetic diseases, offering hope for those affected by these conditions.